No supply problems of Influenza vaccines

Published: 2001-10-24 06:57:00

Updated: 2001-10-24 06:57:00

Almost every year the supply of influenza virus vaccine had problems but it may not repeat this year by additional supply of 1.5 million doses to the previous year volume.

The vaccine production company already secured the strains (WHO determined A type: New Calidonia and Moscow, B type: Siche...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK